An ongoing dialogue on HIV/AIDS, infectious diseases,
March 3rd, 2010
Ritonavir Tablets: Any Experience Out There Yet?
Ritonavir tablets have been approved, and are apparently now in pharmacies. The capsules will also remain available for the foreseeable future.
However, I haven’t switched anyone over from the capsules yet, and neither has anyone else in our practice.
Would be interested in hearing how it’s going so far — best news would be that the tablets are both more convenient and have fewer side effects, but we know from the switch to Kaletra tablets that the latter might not occur.
(Which surprised me, I have to admit — thought the tablets would be better tolerated, but it was about the same.)
So … if you’ve switched patients to from the capsules to the tablets, comment away!
Categories: HIV, Patient Care
Tags: antiretroviral therapy, HIV, ritonavir
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
2 Responses to “Ritonavir Tablets: Any Experience Out There Yet?”

Paul E. Sax, MD
Contributing Editor
NEJM Journal Watch
Infectious Diseases
Biography | Disclosures | Summaries
Learn more about HIV and ID Observations.
Search this Blog
Follow HIV and ID Observations Posts via Email
Archives
-
-
From the Blog — Most Recent Articles
- My Dog Louie, the Best Dog Ever, Is Seriously Ill September 26, 2025
- Two Drugs, Not Three: The DOLCE Study in Advanced HIV Disease September 19, 2025
- When Required Learning Modules Surprise You (In a Good Way) September 10, 2025
- End-of-Summer Musings — Hepatitis B, Dalbavancin, Alpha-Gal, and More September 4, 2025
- Watching the Chaos at the CDC — with Sadness and Alarm August 29, 2025
NEJM Journal Watch — Recent Infectious Disease Articles
- Can Recombinant Technology Improve Rabies Prevention?
- Is the High-Dose Flu Vaccine Better Than the Standard Dose for Preventing Severe Outcomes?
- Observations from ID and Beyond: Two Drugs, Not Three — The DOLCE Study in Advanced HIV Disease
- Marburg Outbreak! Can Rapid Response Minimize Mortality and Halt Spread?
- The Ryan White HIV/AIDS Program: Critical to Efforts to End the HIV Epidemic
-
Tag Cloud
- Abacavir AIDS antibiotics antiretroviral therapy ART atazanavir baseball Brush with Greatness CDC C diff COVID-19 CROI darunavir dolutegravir elvitegravir etravirine FDA HCV hepatitis C HIV HIV cure HIV testing ID fellowship ID Learning Unit Infectious Diseases influenza Link-o-Rama lyme disease medical education MRSA PEP PrEP prevention primary care raltegravir Really Rapid Review resistance Retrovirus Conference rilpivirine sofosbuvir TDF/FTC tenofovir Thanksgiving vaccines zoster
We have been using generic RTV tablet since 2-3 years in India and all the capsules have been withdrawn since then. The tolerance is good
Sanjay, thanks for the comment. I wonder how your generic ritonavir compares with the version now licensed in the USA.